Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03808818 · ClinicalTrials.gov registry record · NA
Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices
A NA study, sponsored by ECOG-ACRIN Cancer Research Group.
- Completed
- Registry status
- NA
- Development phase
- 306
- Enrollment target
NCT03808818 is a NA study that has completed, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 306 participants.
The verdict
NCT03808818, a NA study, has completed, sponsored by ECOG-ACRIN Cancer Research Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 306 participants
- Enrollment target
Study Summary
This phase II trial studies how well smoking cessation treatment plans work in tobacco-dependent cancer patients when delivered virtually as part of their cancer care in community oncology practices. Virtual information and counseling sessions may help cancer patients quit smoking.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Survey Administration
- DRUG Nicotine Replacement
- OTHER Tobacco Cessation Counseling
- OTHER Behavioral, Psychological or Informational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03808818
The ClinicalTrials.gov registry entry for NCT03808818 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 306 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ECOG-ACRIN Cancer Research Group, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT03808818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03808818 about?
NCT03808818 is a clinical study titled "Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices". This phase II trial studies how well smoking cessation treatment plans work in tobacco-dependent cancer patients when delivered virtually as part of their cancer care in community oncology practices. Virtual information and counseling sessions may help cancer patients quit smoking.
What is the current status of trial NCT03808818?
This trial is currently completed. It is a NA study. The enrollment target is 306 participants. The study started on 2019-08-01. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT03808818?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Survey Administration (OTHER), Nicotine Replacement (DRUG), Tobacco Cessation Counseling (OTHER), Behavioral, Psychological or Informational Intervention (OTHER).
Who is sponsoring clinical trial NCT03808818?
This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.